Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Norton

Showing results (321-330 of 326) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 326 results.
JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.
Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.
Gastroenterology|October 26, 2001
A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulasD A Schwartz, M J Wiersema, K M Dudiak, et al.
Cell|May 19, 2018
Digital Museum of Retinal Ganglion Cells with Dense Anatomy and PhysiologyJ Alexander Bae, Shang Mu, Jinseop S Kim, et al.
BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Journal of the Pediatric Infectious Diseases Society|October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 33

Showing results (321-330 of 326) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 326 results.
JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.
Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.
Gastroenterology|October 26, 2001
A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulasD A Schwartz, M J Wiersema, K M Dudiak, et al.
Cell|May 19, 2018
Digital Museum of Retinal Ganglion Cells with Dense Anatomy and PhysiologyJ Alexander Bae, Shang Mu, Jinseop S Kim, et al.
BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Journal of the Pediatric Infectious Diseases Society|October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 33